Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 15851-15900 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06597539
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary Malignancy
N/ARecruiting
40 participants
Started: Nov 9, 2024 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06496971
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
PHASE3Recruiting
32 participants
Started: Nov 8, 2024 · Completed: Mar 31, 2027
8 conditions1 sponsor2 locations
NCT06888960
Safety Study of CC312 in Autoimmune Disease Patients
EARLY_PHASE1Recruiting
18 participants
Started: Nov 8, 2024 · Completed: Nov 8, 2026
6 conditions1 sponsor1 location
NCT06699680
Phase 1 Study of PRX019 in Healthy Adult Volunteers
PHASE1Recruiting
48 participants
Started: Nov 8, 2024 · Completed: Jan 23, 2026
1 condition1 sponsor1 location
NCT06322810
ESP Versus PIFB for Analgesia in Open Cardiac Surgery: a Randomized Control Trial
NARecruiting
80 participants
Started: Nov 8, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06691555
Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt
N/ARecruiting
66 participants
Started: Nov 8, 2024 · Completed: Nov 30, 2024
6 conditions1 sponsor1 location
NCT06511167
Post-market Surveillance Study to Evaluate the Quality of Life and the Safety and Effectiveness of the TIGR® Matrix After Reconstructive Breast Surgery
N/ARecruiting
135 participants
Started: Nov 8, 2024 · Completed: Jan 31, 2029
1 condition2 sponsors5 locations
NCT06637904
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
NARecruiting
300 participants
Started: Nov 8, 2024 · Completed: Mar 31, 2025
4 conditions1 sponsor2 locations
NCT06512025
Implementation of a Psychoeducational Intervention in New Mothers
NARecruiting
400 participants
Started: Nov 8, 2024 · Completed: Jun 30, 2027
2 conditions4 sponsors2 locations
NCT06517186
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
N/ARecruiting
180 participants
Started: Nov 8, 2024 · Completed: Jun 30, 2026
2 conditions7 sponsors6 locations
NCT07134634
Effect of a Vibrating Therapy Ball on Tremor and Daily Activities in Patients With Different Tremor Syndroms
N/ARecruiting
60 participants
Started: Nov 8, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06605209
Safety and Effectiveness of the Peripheral Balloon-Expandable Covered Stent System for Iliac Artery Stenosis/Occlusion. (SELECT)
NARecruiting
130 participants
Started: Nov 8, 2024 · Completed: Dec 15, 2026
1 condition1 sponsor1 location
NCT06849908
Baricitinib in the Treatment of Intestinal Behçet's Syndrome
PHASE2Recruiting
56 participants
Started: Nov 8, 2024 · Completed: Jun 30, 2028
1 condition1 sponsor2 locations
NCT06622434
New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study
PHASE1/PHASE2Recruiting
35 participants
Started: Nov 8, 2024 · Completed: May 8, 2027
1 condition1 sponsor1 location
NCT06468280
Synergistic Effects of PD-1 Antibody and Chemotherapy Followed by Surgery-centric Local Treatment in Patients with Limited-metastatic Gastric Cancer (ROSETTE)
PHASE2Recruiting
84 participants
Started: Nov 8, 2024 · Completed: Dec 31, 2028
2 conditions1 sponsor2 locations
NCT06580158
AI in Outpatient Practice for Diagnosing Aortic Stenosis and Diastolic Dysfunction
N/ARecruiting
2,000 participants
Started: Nov 8, 2024 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT06660381
Psilocybin-assisted Treatment for Cannabis Use Disorder
PHASE1Recruiting
12 participants
Started: Nov 8, 2024 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT06685523
Evaluation of Fractalkine and Its Receptor in Peri-implantitis
NARecruiting
100 participants
Started: Nov 8, 2024 · Completed: May 15, 2025
1 condition1 sponsor1 location
NCT05484973
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
NARecruiting
99 participants
Started: Nov 8, 2024 · Completed: Sep 30, 2026
4 conditions1 sponsor2 locations
NCT06533462
Randomized Controlled Trial of Slow Multiallergen Oral Immunotherapy in Young Children
NARecruiting
80 participants
Started: Nov 8, 2024 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT06541067
Study of Posaconazole Prophylaxis in Patients Receiving Hematopoietic Stem Cell Allograft (allo-HSC) At High Risk of Invasive Fungal Infection (IFI)
PHASE2Recruiting
30 participants
Started: Nov 8, 2024 · Completed: Nov 8, 2028
1 condition1 sponsor1 location
NCT06813456
Implementation of Solid Digital PCR to Support Gold-standard Methods for Evaluation of HER2 Amplification Status: Focus on HER2-low Subtype
N/ARecruiting
234 participants
Started: Nov 8, 2024 · Completed: Dec 1, 2028
1 condition1 sponsor1 location
NCT06958874
Adjunctive Effect of Erythritol on Pocket Closure Rates
NARecruiting
56 participants
Started: Nov 8, 2024 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06325683
Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
PHASE2Recruiting
184 participants
Started: Nov 8, 2024 · Completed: Jul 15, 2028
2 conditions1 sponsor225 locations
NCT06659341
A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation
PHASE1Recruiting
104 participants
Started: Nov 8, 2024 · Completed: Mar 7, 2028
1 condition1 sponsor10 locations
NCT06606808
Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease
PHASE1/PHASE2Recruiting
18 participants
Started: Nov 8, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06824532
Veteran's Perceptions of Ketamine-Assisted Psychotherapy for Depression and End-of-Life
N/ARecruiting
30 participants
Started: Nov 8, 2024 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT06619574
Temporomandibular Joint (TMJ) Positioning Accuracy and Efficiency Using a Dental Compass.
NARecruiting
80 participants
Started: Nov 8, 2024 · Completed: Mar 1, 2027
1 condition2 sponsors1 location
NCT06644196
Creation of a Database of Images of the Eye with the Holographic Doppler Laser
N/ARecruiting
123 participants
Started: Nov 8, 2024 · Completed: Nov 8, 2025
1 condition1 sponsor1 location
NCT06519331
Development of a New Method for Liver Stiffness Measurement Using FibroScan
NARecruiting
114 participants
Started: Nov 8, 2024 · Completed: May 31, 2027
1 condition1 sponsor2 locations
NCT06619613
A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease
PHASE1Recruiting
48 participants
Started: Nov 8, 2024 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT06601998
Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.
N/ARecruiting
650 participants
Started: Nov 8, 2024 · Completed: Jun 8, 2028
3 conditions1 sponsor16 locations
NCT05800990
Eating to Adjust the Timing System
NARecruiting
24 participants
Started: Nov 8, 2024 · Completed: Aug 31, 2027
1 condition2 sponsors1 location
NCT06614192
A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer
PHASE3Recruiting
460 participants
Started: Nov 8, 2024 · Completed: Oct 31, 2028
1 condition1 sponsor51 locations
NCT06690996
A Study of LY4005130 in Healthy Participants
PHASE1Recruiting
140 participants
Started: Nov 8, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06406049
Finishing HIV Project
NARecruiting
624 participants
Started: Nov 8, 2024 · Completed: Nov 15, 2029
1 condition2 sponsors1 location
NCT06639074
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
PHASE2Recruiting
78 participants
Started: Nov 8, 2024 · Completed: Dec 31, 2027
18 conditions1 sponsor3 locations
NCT06867991
Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis
PHASE3Recruiting
200 participants
Started: Nov 8, 2024 · Completed: Nov 8, 2027
1 condition1 sponsor2 locations
NCT06693089
Metacognitive Interpersonal Therapy Across Transdiagnostic Eating Disorders, Including Underweight
NARecruiting
64 participants
Started: Nov 8, 2024 · Completed: Feb 7, 2026
10 conditions8 sponsors2 locations
NCT06234501
Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism
NARecruiting
40 participants
Started: Nov 8, 2024 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT06249867
A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS
PHASE2Recruiting
30 participants
Started: Nov 8, 2024 · Completed: Sep 30, 2027
1 condition2 sponsors2 locations
NCT06682039
Attention Bias Modification for the Improvement of Anxiety in Adolescent and Young Adult Cancer Survivors
NARecruiting
60 participants
Started: Nov 8, 2024 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT06484387
Study of Intra- and Interpersonal Multimodal Synchronizations in a Social Interaction in Individuals with a Diagnosis of Schizophrenia.
NARecruiting
120 participants
Started: Nov 8, 2024 · Completed: Nov 8, 2025
1 condition2 sponsors1 location
NCT06566443
Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer
PHASE1Recruiting
15 participants
Started: Nov 8, 2024 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT05986578
Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder
NARecruiting
75 participants
Started: Nov 8, 2024 · Completed: Jun 30, 2028
1 condition2 sponsors1 location
NCT06648096
Afatinib in Patients with Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
PHASE1/PHASE2Recruiting
25 participants
Started: Nov 8, 2024 · Completed: Dec 31, 2028
2 conditions2 sponsors2 locations
NCT06518005
Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome
PHASE2Recruiting
3 participants
Started: Nov 8, 2024 · Completed: Sep 30, 2030
1 condition2 sponsors1 location
NCT06568536
Measuring Brain Complexity to Detect and Predict Recovery of Consciousness in the ICU
NARecruiting
120 participants
Started: Nov 8, 2024 · Completed: Aug 1, 2029
1 condition2 sponsors2 locations
NCT06641908
Anti-GD2 ADC M3554 in Advanced Solid Tumors
PHASE1Recruiting
52 participants
Started: Nov 8, 2024 · Completed: Mar 27, 2028
1 condition2 sponsors9 locations
NCT06380686
Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
N/ARecruiting
120 participants
Started: Nov 7, 2024 · Completed: Nov 30, 2030
4 conditions2 sponsors2 locations